DNA mismatch repair (MMR) is essential for maintaining the integrity of mammalian genomes by removing misincorporated nucleotides that result from erroneous replication and by mediating a DNA damage response (DDR) after exposure to genotoxic agents. Mutations in mammalian MMR genes are causative in hereditary non-polyposis colorectal cancer /Lynch syndrome (HNPCC/LS) and many sporadic cancers. Importantly, loss of MMR not only increases genomic mutation rates but also the resistance of tumors to conventional chemotherapeutic agents. Our research program focuses on elucidating the different biological functions of the individual MMR genes involved in mismatch recognition and excision and assessing their importance for tumor suppression and the response to chemotherapeutic agents. In the past funding period, we determined that MMR-dependent DDR is essential for tumor suppression and the sensitivity of tumors to chemotherapeutic treatment. In new preliminary studies, we have modeled the pathogenic S144I HNPCC/LS mutation located in the MSH6-PWWP protein interaction domain, in knock-in mice. PWWP domains have been shown to directly interact with methylated lysines in histones suggesting a novel interaction of MMR proteins with chromatin. The MSH6S144I mutation is unique, because in contrast to all other known MMR mutations, it only impairs the DDR function but does not affect the repair of mismatched bases. This mutation will allow us for the first time to unequivocally test the hypothesis that MMR-dependent DDR function is essential for suppression of diet and carcinogen-induced tumorigenesis and also identify novel MSH6-chromatin interactions. We have also found in VCMsh2loxP knockout mice that were developed by us and serve as excellent preclinical models of HNPCC/LS, that treatment of intestinal tumors with rapamycin results in dramatic tumor regression and increased life span, suggesting that rapamycin treatment may have clinical impact in being specifically effective in the treatment of MMR-deficient tumors. To determine the molecular mechanisms underlying the regression of MMR-deficient intestinal tumors in response to rapamycin treatment we will test the idea that the accumulation of rapamycin- induced oxidative DNA damage and autophagy cooperate to cause selective sensitivity in MMR-deficient intestinal tumors. Finally, we propose to determine the importance of MMR in intestinal tumor stem cells for the sensitivity or resistance of intestinal tumors to chemotherapeutic treatment.

Public Health Relevance

The DNA mismatch repair system (MMR) is essential for maintaining the integrity of mammalian genomes and defects in MMR are the cause of the cancer syndrome hereditary nonpolyposis colorectal cancer (HNPCC) or Lynch syndrome and a significant number of sporadic cancers in humans. We are studying genetically modified mouse lines with mutations in key MMR genes to determine the impact on DNA repair functions, the ability of MMR to suppress tumor formation and the response of tumors to chemotherapeutic treatment. Our studies will provide a better understanding of the biological functions of this important genome maintenance system and of the molecular mechanisms that prevent tumor formation in mammals and may lead to novel strategies for the treatment of tumors with MMR defects.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA076329-17
Application #
8627130
Study Section
Cancer Etiology Study Section (CE)
Program Officer
Okano, Paul
Project Start
1997-12-01
Project End
2018-03-31
Budget Start
2014-04-01
Budget End
2015-03-31
Support Year
17
Fiscal Year
2014
Total Cost
$369,167
Indirect Cost
$148,109
Name
Albert Einstein College of Medicine
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
110521739
City
Bronx
State
NY
Country
United States
Zip Code
10461
Zhang, Yongwei; Werling, Uwe; Edelmann, Winfried (2014) Seamless Ligation Cloning Extract (SLiCE) cloning method. Methods Mol Biol 1116:235-44
Dietlein, Felix; Thelen, Lisa; Jokic, Mladen et al. (2014) A functional cancer genomics screen identifies a druggable synthetic lethal interaction between MSH3 and PRKDC. Cancer Discov 4:592-605
Ene, Adriana C; Park, Stephanie; Edelmann, Winfried et al. (2013) Caspase 9 is constitutively activated in mouse oocytes and plays a key role in oocyte elimination during meiotic prophase progression. Dev Biol 377:213-23
Schaetzlein, Sonja; Chahwan, Richard; Avdievich, Elena et al. (2013) Mammalian Exo1 encodes both structural and catalytic functions that play distinct roles in essential biological processes. Proc Natl Acad Sci U S A 110:E2470-9
Zhang, Yongwei; Werling, Uwe; Edelmann, Winfried (2012) SLiCE: a novel bacterial cell extract-based DNA cloning method. Nucleic Acids Res 40:e55
Chahwan, Richard; van Oers, Johanna M M; Avdievich, Elena et al. (2012) The ATPase activity of MLH1 is required to orchestrate DNA double-strand breaks and end processing during class switch recombination. J Exp Med 209:671-8
Chahwan, Richard; Edelmann, Winfried; Scharff, Matthew D et al. (2011) Mismatch-mediated error prone repair at the immunoglobulin genes. Biomed Pharmacother 65:529-36
Wang, Yuxun; Zhang, Weijia; Edelmann, Lisa et al. (2010) Cis lethal genetic interactions attenuate and alter p53 tumorigenesis. Proc Natl Acad Sci U S A 107:5511-5
Peled, Jonathan U; Sellers, Rani S; Iglesias-Ussel, Maria D et al. (2010) Msh6 protects mature B cells from lymphoma by preserving genomic stability. Am J Pathol 177:2597-608
van Oers, Johanna M M; Roa, Sergio; Werling, Uwe et al. (2010) PMS2 endonuclease activity has distinct biological functions and is essential for genome maintenance. Proc Natl Acad Sci U S A 107:13384-9

Showing the most recent 10 out of 41 publications